Abstract
The use of tandem mass spectrometry (MS/MS) for screening of inherited metabolic disease in newborns has afforded many unique opportunities in the understanding of the benefits early their early detection, diagnosis and treatment. From the standpoint of the laboratory and modern analytical methods, the use of MS based analysis demonstrated that a multiple metabolite-multiple disease screen-one method approach expanded screening significantly. MS/MS and newborn screening has served as a model of one type of approach in preventative health care that has shown proven benefits. It has been nearly 20 years since the introduction of MS/MS analysis of dried blood spots from newborns. There have been many lessons learned in both the analytical approach as well as follow-up at the bedside. These lessons can be applied to future applications of MS/MS in newborn screening as well as other areas of metabolism and metabolic profiles such as that from acquired disease, environmental disease and other factors such as nutrition and age. The use of a highly specific, sensitive and multiplex platform such as MS/MS will continue to grow and experience in the newborn screening application will insure this outcome.
Keywords: Metabolism, mass spectrometry, metabolic profile, isotope dilution, acylcarnitine, amino acids, dried blood spot, tandem mass spectrometry, screening, bedside, environmental disease, proteomics
Current Pharmaceutical Biotechnology
Title: Altered Metabolism and Newborn Screening Using Tandem Mass Spectrometry: Lessons Learned from the Bench to Bedside
Volume: 12 Issue: 7
Author(s): > H. Chace and Alan R. Spitzer
Affiliation:
Keywords: Metabolism, mass spectrometry, metabolic profile, isotope dilution, acylcarnitine, amino acids, dried blood spot, tandem mass spectrometry, screening, bedside, environmental disease, proteomics
Abstract: The use of tandem mass spectrometry (MS/MS) for screening of inherited metabolic disease in newborns has afforded many unique opportunities in the understanding of the benefits early their early detection, diagnosis and treatment. From the standpoint of the laboratory and modern analytical methods, the use of MS based analysis demonstrated that a multiple metabolite-multiple disease screen-one method approach expanded screening significantly. MS/MS and newborn screening has served as a model of one type of approach in preventative health care that has shown proven benefits. It has been nearly 20 years since the introduction of MS/MS analysis of dried blood spots from newborns. There have been many lessons learned in both the analytical approach as well as follow-up at the bedside. These lessons can be applied to future applications of MS/MS in newborn screening as well as other areas of metabolism and metabolic profiles such as that from acquired disease, environmental disease and other factors such as nutrition and age. The use of a highly specific, sensitive and multiplex platform such as MS/MS will continue to grow and experience in the newborn screening application will insure this outcome.
Export Options
About this article
Cite this article as:
H. Chace > and R. Spitzer Alan, Altered Metabolism and Newborn Screening Using Tandem Mass Spectrometry: Lessons Learned from the Bench to Bedside, Current Pharmaceutical Biotechnology 2011; 12 (7) . https://dx.doi.org/10.2174/138920111795909104
DOI https://dx.doi.org/10.2174/138920111795909104 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance
Current Medicinal Chemistry Inflammation and Thrombophilia in Pregnancy Complications: Implications for Risk Assessment and Clinical Management
Cardiovascular & Hematological Disorders-Drug Targets Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients <i>In vivo</i> and <i>In vitro</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets Peptide Immunotherapies in Type 1 Diabetes: Lessons from Animal Models
Current Medicinal Chemistry Neuropeptides and Epitheliopeptides: Structural and Functional Diversity in an Ancestral Metazoan Hydra
Protein & Peptide Letters Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics’ (‘Spice’) Intake?
CNS & Neurological Disorders - Drug Targets Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Interval Exercise Therapy for Type 2 Diabetes
Current Diabetes Reviews Alzheimer’s Disease and Autistic Spectrum Disorder: Is there any Association?
CNS & Neurological Disorders - Drug Targets Pharmacological and Cellular Therapies to Prevent Restenosis after Percutaneous Transluminal Angioplasty and Stenting
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Inflammatory Pain: The Cellular Basis of Heat Hyperalgesia
Current Neuropharmacology Obesity as a Model of Premature Immunosenescence
Current Immunology Reviews (Discontinued) Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Congenital Disorders of Glycosylation: CDG-I, CDG-II, and Beyond
Current Molecular Medicine Recent Advances in Quality Control of Traditional Chinese Medicines
Combinatorial Chemistry & High Throughput Screening FK506-Binding Proteins and Their Diverse Functions
Current Molecular Pharmacology Benzimidazole: A Multifacted Nucelus for Anticancer Agents
Current Organic Chemistry Blood Pressure and Childhood Obesity
Current Hypertension Reviews